The HAPPINESS Trial: cHAnging the Perceived Pain INtensity in divErSe Populations With Spinal Cord Injury

March 28, 2024 updated by: University of Minnesota

cHAnging the Perceived Pain INtensity in divErSe Populations With Spinal Cord Injury

Chronic neuropathic pain affects 69% of adults with spinal cord injury (SCI). Current treatment options are limited (primarily pain medications) with insufficient benefits and significant risks for addiction and adverse effects. Of the available mind and body approaches, Qigong is the most accessible for adults with SCI with evidence for effectiveness in reducing pain, but there is insufficient evidence to make recommendations for adults with SCI. Thus, the feasibility of Qigong in SCI needs to be established.

To support our feasibility study, we investigated a 12-week remote Qigong program in adults with SCI and neuropathic pain. We recruited 23 adults with SCI, 18 completed the study, and 12 completed the 1-year follow-up. They practiced Qigong 138% of the required intensity (which was, at least 3x/week with Qigong video through the internet). Their pain was reduced by 44% after 12 weeks of Qigong practice and was still reduced at the 6-week and 1-year follow-up. However, three key elements need to be addressed before performing a larger effectiveness study: (1) feasibility/acceptability of Qigong from adults with SCI of diverse backgrounds; (2) feasibility of the study design with control group); and (3) objective outcome measures.

This R34 feasibility study, the HAPPINESS trial (cHAnging the Perceived Pain INtensity in divErSe populations with Spinal cord injury), will expand on our prior study to consolidate feasibility with a rigorous protocol. We will address the following aims: AIM 1. Identify the facilitators/barriers to participating in a Qigong study through focus groups/interviews with stakeholders from diverse backgrounds, defined as Hispanics, veterans, and adults living in rural, underserved areas. AIM 2. Establish the feasibility of study design/methods of the HAPPINESS trial in adults with SCI (at least 50% of diverse backgrounds) through pre-specified targets for recruitment/enrollment, feasibility, and acceptability of design and outcomes. Using a Phase I randomized controlled trial design, 40 adults with SCI-related neuropathic pain will be randomized to 12-week remote Qigong intervention OR a short daily pain management survey that can be completed on phone/iPad/computer + 6-month follow-up. The study results will facilitate a rigorous structure to design larger effectiveness studies and facilitate a clear pathway for researchers to investigate Qigong and other mind-body approaches for whole-person health in diverse groups of adults with chronic/neurological disorders.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Ann Van de Winckel, PhD, MSPT, PT
  • Phone Number: 612-625-1191
  • Email: avandewi@umn.edu

Study Locations

    • Minnesota
      • Minneapolis, Minnesota, United States, 55414
        • Recruiting
        • University of Minnesota
        • Contact:
          • Van De Winckel Van

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 18+ years old
  • medically stable
  • with neuropathic pain above 0 on the Neuropathic Pain Questionnaire (NPQ) scale
  • willing to participate in a remote Qigong intervention (from any location with internet connection)
  • fluent in English or Spanish
  • access to the internet and a computer/iPad or smartphone

Exclusion Criteria:

  • uncontrolled seizure disorder
  • cognitive impairment and/or communicative disability (e.g., due to brain injury) preventing them from following directions or from learning
  • ventilator dependency
  • major medical complications
  • pressure ulcers hindering prolonged sitting or lying down
  • (planning to become) pregnant or planning a major surgery during the study (given study duration, regular Qigong practice, and frequent check-ins)
  • regular Tai Chi or Qigong practice in the past 6 months (3x/week or more)
  • currently engaged in other rehabilitation programs that would influence outcomes

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental group
adults with SCI-related neuropathic pain with at least 50% from diverse groups randomized to experimental group
a Qigong introduction class and a 12-week remote Qigong intervention, with a 6-month follow-up
Active Comparator: Active comparison group
adults with SCI-related neuropathic pain with at least 50% from diverse groups randomized to active comparator group
Completing one short survey (2 min) daily through your phone or computer (you will get a survey link through email or text), with a 6-month follow-up.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
recruitment rates
Time Frame: 6 months post-intervention
The proportion of potential participants contacted who agreed to participate
6 months post-intervention
the recruitment rate for complete and incomplete SCI
Time Frame: 6 months post-intervention
Ratio of complete/incomplete SCI.
6 months post-intervention
Attrition rates in Qigong and Manage My Pain app group.
Time Frame: 6 months post-intervention
Proportion of people withdrawing from the study in either group. Drop-out due to unrelated reasons will count as part of the general attrition.
6 months post-intervention
intervention adherence
Time Frame: 6 months post-intervention

the website log times will indicate the date and duration that the video is accessed. From this information, we will collect the number of minutes that they practice.

This information will be checked with the self-report during the weekly calls, in which they will report the number of minutes per week they have practiced.

6 months post-intervention
the frequency of use of the Manage My Pain app (recommended daily check in)
Time Frame: 6 months post-intervention
Weekly/ monthly check-ins (reporting min/week of practice) to identify facilitators and barriers to practicing Qigong. The website logs time and duration of video access. A Qigong certified instructor will do 1:1 Qigong session with each participant via zoom monthly for quality control/to give guidance.
6 months post-intervention
Feasibility of adhering to the collection of quantitative measure 1
Time Frame: 6 months post-intervention
% Adherence in completing all assessments during the study and in the monthly follow-up phase
6 months post-intervention
Feasibility of adhering to the collection of quantitative measure 2
Time Frame: 6 months post-intervention
% Adherence to wearing the Garmin Vivosmart 5 and sending the data through their phone App
6 months post-intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ann Van de Winckel, PhD, MSPT, PT, University of Minnesota

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 21, 2024

Primary Completion (Estimated)

March 21, 2027

Study Completion (Estimated)

March 21, 2027

Study Registration Dates

First Submitted

November 7, 2023

First Submitted That Met QC Criteria

November 15, 2023

First Posted (Actual)

November 20, 2023

Study Record Updates

Last Update Posted (Actual)

April 1, 2024

Last Update Submitted That Met QC Criteria

March 28, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spinal Cord Injuries

Clinical Trials on Qigong

3
Subscribe